The global ultrasound bladder scanners market is growing fruitfully, valued at US$ 122.4 Mn in 2020 and expected to reach US$ 244.4 Mn by 2029. Worldwide increasing urological disorders (urinary tract infections, urinary incontinence, and voiding dysfunction) along with utilization of advanced handheld or portable devices will drive the overall market growth. New technological advancements in the field of mobile technology, improvement in clinical governance and healthcare infrastructure will further spur revenue growth.
The global medical imaging equipment market is increasing competently, projected to grow at a CAGR of 4.9%. Worldwide, increasing diagnostic procedures along with has significantly increased the demand. Inventive product launches in the cardiology, neurology and orthopedics industry, high pool of patients with abundant lifestyle conditions are key factors driving the overall growth of medical imaging equipment market globally.
Breast biopsy procedure refers to extraction of tissue sample from the breast for examination and diagnosis. Due to the advantage of least disfigurement and pain, physicians are increasingly performing minimally invasive biopsy procedures. Therefore, the prime factors that support the market growth of breast biopsy devices are increasing incidence of breast cancer, growing awareness about cancer screening programs and advancing preference for minimally invasive procedures and dedicated systems.
The medical imaging market includes equipment, software and related technologies used to create images of organs, tissues and structures inside the human body. Major technologies include X-ray, ultrasound, magnetic resonance imaging, computed tomography, mammography, fluoroscopy, positron emission tomography and single-photon emission computed tomography. Hospitals, diagnostic imaging centers, clinics and research organizations use these systems for disease screening, diagnosis, treatment planning and patient monitoring.
The global medical imaging market is projected to increase from USD 48.3 billion in 2026 to USD 80.9 billion by 2035, registering a CAGR of 5.9% during the forecast period. Market estimates can differ based on whether imaging software, contrast agents and equipment services are included within the study scope.
The increasing prevalence of cancer, cardiovascular disease, neurological disorders and musculoskeletal conditions is a major growth driver. Aging populations are increasing the need for diagnostic procedures, while greater awareness of early disease detection is supporting regular screening. Investment in hospitals and diagnostic centers across developing countries is also expanding the installed base of imaging equipment.
Artificial intelligence is becoming an important part of medical imaging. AI-supported software can assist radiologists with image analysis, disease detection, workflow prioritization and report preparation. These applications can help manage growing imaging volumes and address shortages of trained radiology professionals. However, AI systems require reliable clinical validation, high-quality data and continued professional oversight.
Hybrid imaging systems represent another important market trend. PET/CT, SPECT/CT and PET/MRI systems combine anatomical and functional information to support more detailed assessment. These systems are used in oncology, cardiology and neurology. Three-dimensional and four-dimensional imaging technologies are also improving treatment planning and procedural guidance.
Portable and point-of-care imaging equipment is gaining demand in emergency departments, intensive-care units, ambulatory centers and remote locations. Compact ultrasound and mobile X-ray systems allow healthcare professionals to conduct examinations close to the patient. Cloud-based image storage and teleradiology platforms are supporting secure access to medical images across different healthcare facilities.
Market growth may be limited by high equipment and maintenance costs, reimbursement pressure and shortages of trained operators. MRI, CT and nuclear imaging systems require significant infrastructure and technical support. Radiation exposure concerns, regulatory requirements and cybersecurity risks involving connected imaging platforms also influence purchasing decisions.
North America leads the market due to its developed healthcare infrastructure, high diagnostic procedure volumes and early adoption of advanced imaging technologies. Europe maintains significant demand supported by established healthcare systems. Asia-Pacific is expected to record fast growth through 2035 as China, India and Southeast Asian countries expand hospitals, diagnostic networks and access to advanced equipment.
Acute Market Reports provides medical imaging market research covering market size, imaging technologies, applications, end users, software developments, competitive analysis, regional opportunities and forecasts through 2035. These reports support equipment manufacturers, healthcare providers, investors and diagnostic organizations in evaluating market developments.